Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.0 implemented, replacing the previous v3.4.3. No visible changes to the study details or pages were detected.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Primary peritoneal carcinoma and Fallopian tube cancer to the study conditions, and updated the page to revision v3.4.2.SummaryDifference0.3%

- Check46 days agoChange DetectedA site-wide Notice was added stating a lapse in government funding may delay data updates and affect operations; a Revision: v3.4.1 was added, replacing the previous v3.4.0.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded UI element: Show glossary, and updated the revision label to Revision: v3.4.0. Adjusted QC/FEAR Act wording and capitalization (Last Update... met QC Criteria; No FEAR Act data) to reflect the new version from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.3.4 was added and the previous v3.3.3 entry was removed from the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.